StreetInsider.com News Articles

Enovis Corp (ENOV) PT Lowered to $27 at BMO Capital

Wed, 02 Sep 2026 09:24:44 -0400

(Updated - September 2, 2026 9:24 AM EDT)

BMO Capital analyst Vik Chopra lowered the price target on Enovis Corp (NYSE: ENOV) to $27.00 (from $30.00) while maintaining a Outperform rating.

The analyst commented: "Margin Headwind, Strategic Tailwind; eCential Strengthens Long-Term Story; We view Enovis’ proposed acquisition of eCential Robotics as a strategically important, but financially back-end-loaded investment that fills the largest remaining gap in the company’s enabling technology portfolio. Enovis expects a net ~100 bps year-overyear margin headwind in 2027 and leverage is expected to increase to ~3.5x at closing before returning to ~3.0x by the end of 2027. We think

Enovis Corp (ENOV) PT Lowered to $27 at BMO Capital

Wed, 02 Sep 2026 09:24:44 -0400

(Updated - September 2, 2026 9:24 AM EDT)

BMO Capital analyst Vik Chopra lowered the price target on Enovis Corp (NYSE: ENOV) to $27.00 (from $30.00) while maintaining a Outperform rating.

Enovis Corp (ENOV) PT Lowered to $24 at JPMorgan

Wed, 02 Sep 2026 09:22:45 -0400

JPMorgan analyst Robbie Marcus lowered the price target on Enovis Corp (NYSE: ENOV) to $24.00 (from $28.00) while maintaining a Neutral rating.

Enovis Corp (ENOV) PT Lowered to $33 at Wells Fargo

Wed, 02 Sep 2026 07:28:06 -0400

Wells Fargo analyst Larry Biegelsen lowered the price target on Enovis Corp (NYSE: ENOV) to $33.00 (from $39.00) while maintaining a Overweight rating.

Enovis Corp (ENOV) PT Lowered to $47 at Citizens as eCential Robotics Acquisition Announced

Wed, 02 Sep 2026 04:13:12 -0400

Citizens analyst David Turkaly lowered the price target on Enovis Corp (NYSE: ENOV) to $47.00 (from $55.00) while maintaining a Market Outperform rating.

The analyst commented, "We reiterate our Market Outperform rating though lower our price target to $47 from $55 on shares of Enovis after the company announced its acquisition of eCential Robotics, a French developer of surgical robotics and enabling tech offerings, for ~€176 mln (~$205 mln, ~€155 mln EV; with up to €35 mln of contingent milestone payments). The transaction is expected to be funded by a combination of cash on hand and credit revolver capacity (which stood

Enovis Corp (ENOV) PT Lowered to $47 at Citizens as eCential Robotics Acquisition Announced

Wed, 02 Sep 2026 04:13:12 -0400

Citizens analyst David Turkaly lowered the price target on Enovis Corp (NYSE: ENOV) to $47.00 (from $55.00) while maintaining a Market Outperform rating.

Enovis makes binding offer to acquire eCential Robotics

Tue, 01 Sep 2026 06:46:12 -0400

Enovis Corporation (NYSE: ENOV) has submitted a binding offer to acquire eCential Robotics, a French surgical robotics company headquartered in Gières, France, with U.S. commercial operations in Franklin, Tennessee, according to a press release.

The transaction is expected to close in the fourth quarter of 2026, subject to regulatory approvals. Before a definitive purchase agreement is signed, the parties must complete an information and consultation process with eCential Robotics' works council under French law.

eCential Robotics develops the Op.n® platform, which combines surgical navigation and active robotics in a single architecture. The platform has received FDA 510(k) clearance for spine surgery in

Enovis makes binding offer to acquire eCential Robotics

Tue, 01 Sep 2026 06:46:12 -0400

eCential Robotics develops the Op.n® platform, which combines surgical navigation and active robotics in a single architecture. The platform has received FDA 510(k) clearance for spine surgery in

eCential Robotics Announces Binding Offer from Enovis

Tue, 01 Sep 2026 06:45:00 -0400

eCential Robotics platform to join Enovis' enabling technology portfolio.

GRENOBLE, France and FRANKLIN, Tenn., Sept. 1, 2026 /PRNewswire/ -- eCential Robotics, a leading developer of enabling technologies and surgical robotics, today announced that Enovis™ Corporation (NYSE: ENOV) has entered a binding offer to acquire the company.

eCential Robotics Announces Binding Offer from Enovis

Tue, 01 Sep 2026 06:45:00 -0400

eCential Robotics platform to join Enovis' enabling technology portfolio.

Form 8-K Enovis CORP For: Aug 31

Tue, 01 Sep 2026 06:31:00 -0400

si-local-file:///var/storage/secattach/20260901/27008421.html

Enovis to acquire eCential Robotics for up to €211M

Tue, 01 Sep 2026 06:30:23 -0400

Enovis Corporation (NYSE: ENOV) has entered into a binding offer to acquire eCential Robotics, a surgical robotics developer based in Grenoble, France, according to a company statement.

Under the terms of the agreement, Enovis will pay an upfront enterprise value of €155 million, corresponding to cash consideration of approximately €176 million to eCential Robotics shareholders at closing. An additional €35 million in contingent consideration may be paid upon the achievement of certain milestones. Enovis plans to fund the transaction through cash on its balance sheet and its existing revolving credit facility.

The transaction is expected to close by year-end 2026, subject to

Enovis agrees to acquire eCential Robotics for up to €211M

Tue, 01 Sep 2026 06:30:14 -0400

Enovis Corporation (NYSE: ENOV) has entered into a binding offer to acquire eCential Robotics, a surgical robotics developer based in Grenoble, France, for an upfront enterprise value of €155 million, according to a company press release.

Under the terms of the agreement, Enovis will pay approximately €176 million in cash to eCential Robotics shareholders at closing, plus up to €35 million in contingent consideration tied to certain performance milestones. Enovis plans to fund the transaction using cash on hand and borrowings under its existing revolving credit facility.

The transaction is expected to close by year-end 2026, pending regulatory approvals and completion of

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Tue, 01 Sep 2026 06:30:00 -0400

Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room.
Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub.

Dallas, TX, Sept. 01, 2026 (GLOBE NEWSWIRE) -- – Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced today that it has entered into a binding offer to acquire eCential Robotics, a leading developer of enabling technologies and surgical robotics. The acquisition expands the ASTRA™ enabling technology platform with robotic automation capabilities, creating a more comprehensive ecosystem

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Tue, 01 Sep 2026 06:30:00 -0400

Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room.
Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub.

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Tue, 01 Sep 2026 06:30:00 -0400

Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room.
Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub.

Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics

Tue, 01 Sep 2026 06:30:00 -0400

Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room.
Creates a robotics center of excellence in Grenoble, France, a talent rich medical technology hub.

Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Mon, 31 Aug 2026 16:15:00 -0400

Dallas, TX, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in the 2026 Wells Fargo HealthCare conference on Tuesday, September 8, 2026 at the Encore Boston Harbor.

Damien McDonald, Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat session at 1:30 p.m. Eastern Time. A link to the live audio webcast, as well as a replay of the event, will be available on the Company’s website under the Investors tab at Events and Presentations.

Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Mon, 31 Aug 2026 16:15:00 -0400

Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Mon, 31 Aug 2026 16:15:00 -0400

Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Mon, 31 Aug 2026 16:15:00 -0400

Enovis Corp (ENOV) PT Lowered to $45 at Canaccord

Mon, 17 Aug 2026 06:59:07 -0400

Canaccord analyst Kyle Rose lowered the price target on Enovis Corp (NYSE: ENOV) to $45.00 (from $50.00) while maintaining a Buy rating.

Form SCHEDULE 13G Enovis CORP Filed by: Rubric Capital Management LP

Fri, 14 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260814/26930148.html

Form SCHEDULE 13G Enovis CORP Filed by: Rubric Capital Management LP

Fri, 14 Aug 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260814/26930148.html

Enovis Corp (ENOV) PT Raised to $30 at BMO Capital

Fri, 07 Aug 2026 08:26:39 -0400

BMO Capital analyst Vik Chopra raised the price target on Enovis Corp (NYSE: ENOV) to $30.00 (from $29.00) while maintaining a Outperform rating.